SG11201913520YA - Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same - Google Patents

Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same

Info

Publication number
SG11201913520YA
SG11201913520YA SG11201913520YA SG11201913520YA SG11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA
Authority
SG
Singapore
Prior art keywords
preparing
same
aminopyrimidine derivatives
synthesis
novel intermediates
Prior art date
Application number
SG11201913520YA
Inventor
Sang-Ho Oh
Ja-Heouk Khoo
Jong-Chul Lim
Doo-Byung Lee
Jung-Ae Lee
Jun-Sup Lee
Hyun Ju
Woo-Seob Shin
Sang-Seol Jeon
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of SG11201913520YA publication Critical patent/SG11201913520YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
SG11201913520YA 2017-07-28 2018-07-25 Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same SG11201913520YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170096220 2017-07-28
PCT/KR2018/008381 WO2019022486A1 (en) 2017-07-28 2018-07-25 Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same

Publications (1)

Publication Number Publication Date
SG11201913520YA true SG11201913520YA (en) 2020-02-27

Family

ID=65040817

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201913520YA SG11201913520YA (en) 2017-07-28 2018-07-25 Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same

Country Status (26)

Country Link
US (1) US10858353B2 (en)
EP (1) EP3658553B1 (en)
JP (1) JP7216704B2 (en)
KR (1) KR20190013554A (en)
CN (1) CN111032650A (en)
AU (1) AU2018308039B2 (en)
BR (1) BR112020001396A2 (en)
CA (1) CA3069408A1 (en)
CO (1) CO2020000595A2 (en)
DK (1) DK3658553T3 (en)
EA (1) EA038856B1 (en)
ES (1) ES2923278T3 (en)
HR (1) HRP20220848T1 (en)
HU (1) HUE059501T2 (en)
IL (1) IL271974B (en)
LT (1) LT3658553T (en)
MA (1) MA49703A (en)
PH (1) PH12020500070A1 (en)
PL (1) PL3658553T3 (en)
PT (1) PT3658553T (en)
RS (1) RS63497B1 (en)
SA (1) SA520411120B1 (en)
SG (1) SG11201913520YA (en)
SI (1) SI3658553T1 (en)
UA (1) UA125664C2 (en)
WO (1) WO2019022486A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020230091A1 (en) 2019-05-14 2020-11-19 Janssen Biotech, Inc. Combination therapies with bispecific anti-egfr/c-met antibodies and third generation egfr tyrosine kinase inhibitors
US11850248B2 (en) 2019-05-14 2023-12-26 Yuhan Corporation Therapies with 3rd generation EGFR tyrosine kinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101663637B1 (en) * 2009-11-13 2016-10-07 제노스코 Kinase inhibitors
CN105461695B (en) * 2014-09-29 2018-03-27 齐鲁制药有限公司 Pyrimidine or pyrrolotriazine derivatives and its production and use
PT3207035T (en) * 2014-10-13 2020-02-19 Yuhan Corp Compounds and compositions for modulating egfr mutant kinase activities
CN104788427B (en) * 2015-02-05 2017-05-31 上海泓博智源医药股份有限公司 3 (2 pyrimdinyl-amino) phenylacryloyl amine compounds and its application
WO2016173438A1 (en) * 2015-04-29 2016-11-03 南京明德新药研发股份有限公司 Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
WO2017027768A1 (en) * 2015-08-13 2017-02-16 The Broad Institute, Inc. Compositions and methods for treating tuberculosis
PT3658547T (en) * 2017-07-28 2023-10-20 Yuhan Corp Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same

Also Published As

Publication number Publication date
PH12020500070A1 (en) 2020-12-07
CN111032650A (en) 2020-04-17
LT3658553T (en) 2022-09-12
AU2018308039A1 (en) 2020-01-30
CO2020000595A2 (en) 2020-05-05
IL271974A (en) 2020-02-27
JP2020528437A (en) 2020-09-24
CA3069408A1 (en) 2019-01-31
KR20190013554A (en) 2019-02-11
US10858353B2 (en) 2020-12-08
AU2018308039B2 (en) 2022-04-14
DK3658553T3 (en) 2022-07-25
ES2923278T3 (en) 2022-09-26
UA125664C2 (en) 2022-05-11
EP3658553A4 (en) 2021-04-21
PL3658553T3 (en) 2022-10-10
RS63497B1 (en) 2022-09-30
BR112020001396A2 (en) 2020-08-11
HRP20220848T1 (en) 2022-10-14
MA49703A (en) 2021-04-21
SA520411120B1 (en) 2022-08-25
WO2019022486A1 (en) 2019-01-31
PT3658553T (en) 2022-09-23
IL271974B (en) 2022-08-01
EA038856B1 (en) 2021-10-28
HUE059501T2 (en) 2022-11-28
JP7216704B2 (en) 2023-02-01
EP3658553A1 (en) 2020-06-03
EP3658553B1 (en) 2022-06-15
SI3658553T1 (en) 2022-10-28
US20200207750A1 (en) 2020-07-02
EA202090385A1 (en) 2020-09-09

Similar Documents

Publication Publication Date Title
EP3645529A4 (en) Process for preparing lifitegrast and intermediates thereof
EP3694499A4 (en) Novel process for the preparation of lifitegrast
EP3617195A4 (en) Novel tetrahydronaphthyl urea derivatives
EP3421502C0 (en) Process for the production of thermally modified starch
IL292429B2 (en) Improved process for preparing aminopyrimidine derivatives
EP3265455A4 (en) Chemical process for preparing pyrimidine derivatives and intermediates thereof
IL271974A (en) Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
ZA201907517B (en) Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
PT3759082T (en) Process for the synthesis of 6-chloromethyluracil
HK1255476A1 (en) Process for the synthesis of intermediates of nebivolol
IN2015CH02092A (en)
IL259332A (en) Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives
IS2977B (en) Process for the preparation of intermediates useful in the synthesis of eluxadoline
PL3609877T3 (en) Process for the synthesis of firocoxib
PL3704100T3 (en) Novel process for the preparation tavaborole and its intermediates
LT3713939T (en) Improved process for the synthesis of linker-drug vc-seco
RS63067B1 (en) Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
PL3612534T3 (en) Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
MX2018001296A (en) Process for the synthesis of ravidasvir.
HUP1500451A2 (en) Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates